Results 21 to 30 of about 50,069 (258)

Shifts in medical cannabis use in Canada during the COVID-19 pandemic

Health Promotion and Chronic Disease Prevention in Canada, 2023
IntroductionThe COVID-19 pandemic has had widespread secondary negative health impacts including loss of material security and exacerbation of mental illness in at-risk populations.
Stephanie Lake, Ziva D. Cooper, Kaye Ong, Philippe Lucas   +3 more
doaj   +1 more source

Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution

Journal of Cannabis Research, 2021
Background People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat
Kevin F. Boehnke, Evangelos Litinas, Brianna Worthing, Lisa Conine, Daniel J. Kruger   +4 more
doaj   +1 more source

Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes

Implementation Science, 2021
Background Thirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition.
Emma E. McGinty, Kayla N. Tormohlen, Colleen L. Barry, Mark C. Bicket, Lainie Rutkow, Elizabeth A. Stuart   +5 more
doaj   +1 more source

Medical cannabis identity and public health paternalism

Public Health in Practice, 2023
Objectives: State-dependent and variable lists of medical conditions granting access to medical cannabis in the United States may be an example of public health paternalism.
Amanda Reiman, Joshua S. Meisel, Rielle Capler, Darcey Paulding McCready   +3 more
doaj   +1 more source

Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

Gynecologic Oncology Reports, 2020
Research within a gynecologic oncology population has lagged behind the uptake in use of medical cannabis for symptom control. This study seeks to evaluate patient experience with prescribed medical cannabis obtained through licensed dispensaries in ...
Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, Gary Altwerger   +17 more
doaj   +1 more source

Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry

Brain and Behavior, 2023
Introduction : There are limited therapeutic options for individuals with fibromyalgia. The aim of this study is to analyze changes in health‐related quality of life and incidence of adverse events of those prescribed cannabis‐based medicinal products ...
Claire Wang, Simon Erridge, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Rahul Guru, Wendy Holden, James J. Rucker, Michael W. Platt, Mikael H. Sodergren   +10 more
doaj   +1 more source

Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada

Frontiers in Public Health, 2021
With the medical use of cannabis permitted in Canada since 2001, patients seek to use this botanical drug to treat a range of medical conditions. However, many healthcare practitioners express the need for further scientific evidence around the use of ...
Shaina P. Cahill, Stephanie E. Lunn, Patrick Diaz, Jonathan E. Page, Jonathan E. Page   +4 more
doaj   +1 more source

Canadians’ use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status

BMC Medicine
Background There has been a precipitous decline in authorizations for medical cannabis since non-medical cannabis was legalized in Canada in 2018. This study examines the demographic and health- and medical cannabis-related factors associated with ...
Lynda G. Balneaves, Ashleigh Brown, Matthew Green, Erin Prosk, Lucile Rapin, Max Monahan-Ellison, Eva McMillan, Jonathan Zaid, Michael Dworkind, Cody Z. Watling   +9 more
doaj   +1 more source

Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response

Frontiers in Medicine, 2022
Legalized use of cannabis products and the rising interest in their therapeutic benefits have opened up new opportunities for therapy and marketing. However, the marked variability in formulations, administration modes, therapeutic regimens, and inter ...
Yaron Ilan, Yaron Ilan
doaj   +1 more source

Microneedle Technology in Psoriasis Management: Mechanistic Insights, Technological Innovation, Clinical Progress, and Challenges

Advanced Healthcare Materials, EarlyView.
This review explores the evolving role of microneedle systems in psoriasis management, highlighting their potential for enhanced drug delivery, diagnosis, and disease monitoring. It also discusses unmet clinical needs for psoriasis management and technical challenges, while outlining strategic directions to advance microneedle integration into routine ...
Fatma Moawad, Yasmine Ruel, Roxane Pouliot, Davide Brambilla   +3 more
wiley   +1 more source